Acute Phase Reactants
Products for Acute Phase Reactants
- Cat.No. Product Name Information
-
GC49118
10-hydroxy Warfarin
A metabolite of (R)-warfarin
-
GC18219
6-hydroxy Warfarin
6-hydroxy Warfarin is a metabolite of (+)-warfarin , which is a weaker vitamin K antagonist than (-)-warfarin .
-
GC40529
7-hydroxy Warfarin
7-hydroxy Warfarin is a metabolite of (-)-warfarin, which is a more potent vitamin K antagonist than (+)-warfarin.
-
GC52359
ATX-100
An ionizable cationic lipid
-
GC49784
AZD 2716
An sPLA2 inhibitor
-
GC90993
CL4F8-6
An ionizable cationic lipid
-
GC49266
Compstatin (trifluoroacetate salt)
ICVVQDWGHHRCT
A peptide inhibitor of complement activation
-
GC49131
Dehydro Warfarin
NSC 289346
A metabolite of (±)-warfarin
-
GC52193
Eptifibatide
Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity.
-
GC90684
Lipid 2,2(8,8) 4C CH3
An ionizable cationic lipid
-
GC90490
PMX-53 (trifluoroacetate salt)
A C5a receptor antagonist
-
GC49107
Rosuvastatin lactone
(+)-Rosuvastatin lactone, Rosuvastatin-5S-lactone, RSTL
The lactone form of rosuvastatin
-
GC48060
Rosuvastatin-d6 (sodium salt)
An internal standard for the quantification of rosuvastatin
-
GC72527
S-(-)-Warfarin
-
GC52084
YSK05
YSK05 is a pH-sensitive cationic lipid. YSK05 improves the intracellular trafficking of non-viral vectors. YSK05-MEND shows significantly good gene silencing activity and hemolytic activity. YSK05 overcomes the suppression of endosomal escape by PEGylation. YSK05 effectively enhances siRNA delivery both in vitro and in vivo.